Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,827 JPY | +0.75% | -0.84% | 0.00% |
06/05 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
06/05 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.15B | |
+16.85% | 342B | |
-8.24% | 67.79B | |
+2.91% | 30.73B | |
+24.37% | 24.07B | |
+10.08% | 14.57B | |
+15.57% | 10.24B | |
+21.30% | 9.4B | |
-5.46% | 6.66B | |
+4.77% | 4.87B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- Unity Biotechnology Adds More Patients, Extends Length of Trial of Prospective Macular Edema Treatment